Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle (Q38171298)

30 August 2017

title

Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle (English)

1 reference

30 August 2017

0 references

cognitive dysfunction

1 reference

A Popa-Wagner

1

1 reference

30 August 2017

Ana-Maria Buga

series ordinal

2

1 reference

30 August 2017

B Popescu

series ordinal

3

1 reference

30 August 2017

D Muresanu

series ordinal

4

1 reference

30 August 2017

language of work or name

1 reference

14 December 2013

1 reference

Journal of Neural Transmission

30 August 2017

published in

1 reference

30 August 2017

volume

122 Suppl 1

1 reference

30 August 2017

page(s)

S47-54

1 reference

A metabolic and functional overview of brain aging linked to neurological disorders.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Incidence of dementia after ischemic stroke: results of a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Neurobiology of vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Changing perspectives regarding late-life dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Multi-infarct dementia. A cause of mental deterioration in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Abnormalities of Glucose Metabolism in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Relationship between cerebral energy metabolism in parietotemporal cortex and hippocampus and mental activity during aging in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Neurovascular regulation in the normal brain and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Converging pathogenic mechanisms in vascular and neurodegenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Glial regulation of the cerebral microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Prevalence of dementia disorders in the oldest-old: an autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Large and small artery cross-talk and recent morbidity-mortality trials in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Alzheimer-like changes in rat models of spontaneous diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Cerebral blood flow response to functional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Cognitive impairment with vascular impairment and degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Where vascular meets neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Neuropathologic substrates of ischemic vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Brain endothelial cells and the glio-vascular complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1129-3

No disease in the brain of a 115-year-old woman

21 January 2018

1 reference

12 December 2020

Pathogenesis of cerebral amyloid angiopathy

1 reference

12 December 2020

The effects of additional pathology on the cognitive deficit in Alzheimer disease.

1 reference

12 December 2020

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients

1 reference

12 December 2020

Vascular cognitive impairment: dementia biology and translational animal models

1 reference

12 December 2020

Can disturbed brain microcirculation cause Alzheimer's disease?

1 reference

12 December 2020

Regulation of the cerebral circulation

1 reference

12 December 2020

Vascular-ischemic dementia: an update

1 reference

12 December 2020

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

1 reference

12 December 2020

Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region

1 reference

12 December 2020

Mice as models: transgenic approaches and Alzheimer's disease.

1 reference

12 December 2020

Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.

1 reference

12 December 2020

Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

1 reference

12 December 2020

10.1007/S00702-013-1129-3

Identifiers

DOI

1 reference

30 August 2017

1 reference